Mild hypothermia and mk-801 have similar but not additive degrees of cerebroprotection in the rat permanent focal ischemia model

Vincent I. Frazzini, Christopher J. Winfree, Haroon F. Choudhri, Charles J. Prestigiacomo, Robert A. Solomon

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

ALTHOUGH NOT THE sole factor, glutamate-mediated excitotoxicity is accepted as a major mechanism of ischemic neuronal damage. MK-801 and mild hypothermia, two cerebroprotective modalities, which have been documented to alter glutamatergic action, were tested in the rat middle cerebral artery occlusion (MCAO) model simulating permanent focal ischemia. We administered normothermic (37°C) animals with either MK-801 (1.0 mg/kg 30 min before MCAO or 2.5 mg/kg 30 min before, immediately after, 4 hours, and 8 hours after MCAO) or saline vehicle (30 min before MCAO). Mildly hypothermic (33°C) animals were administered either MK-801 (1.0 mg/kg) or saline vehicle 30 minutes before MCAO. Mild hypothermia was induced over a 20-minute period before MCAO in hypothermic animals. All animals were killed 24 hours after MCAO; their brains were sectioned and stained with 2,3,5-triphenyltetrazolium chloride and their infarct volumes were calculated. In normothermica animals given 1.0 mg/kg and multidose 2.5-mg/kg intraperitoneal injections of MK-801, the infarct volumes (as a percentage of right hemispheric volume) were 16.8 ± 3.5% and 16.3 ± 3.0%, respectively. These infarct volumes were significantly different (P < 0.05; single-variable analysis of variance) from the normothermic, drug-free control (26.8 ± 1.9%), but not significantly different from each other. Analysis of the data using a nonparametric test (Kruskal-Wallis; P = 0.02) confirmed the same significant differences in infarct size. The infarct volumes from the mildly hypothermic groups were not different (1 mg/kg of MK-801, 15.5 ± 2.3% and saline control, 15.4 ± 1.1%). However, the percentage of infarct size in the mildly hypothermic drug-free group was significantly reduced compared with the normothermic drug-free control (P < 0.0005; two-tailed Student's t-test). There was no significant difference between normothermic and mildly hypothermic animals given 1 mg/kg of MK-801. Therefore, in a rat permanent focal cerebral ischemia model, it appears that mild hypothermia and MK-801 offer similar cerebroprotective effects when administered separately, but do not yield additive effects when used in combination.

Original languageEnglish (US)
Pages (from-to)1040-1046
Number of pages7
JournalNeurosurgery
Volume34
Issue number6
DOIs
StatePublished - Jun 1994

Fingerprint

Dizocilpine Maleate
Middle Cerebral Artery Infarction
Hypothermia
Ischemia
Drug and Narcotic Control
Induced Hypothermia
Intraperitoneal Injections
Brain Ischemia
Glutamic Acid
Analysis of Variance
Students
Brain
Pharmaceutical Preparations

Keywords

  • Cerebral ischemia
  • Dizocilpine
  • Hypothermia
  • Middle cerebral artery occlusion
  • Mk-801

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Mild hypothermia and mk-801 have similar but not additive degrees of cerebroprotection in the rat permanent focal ischemia model. / Frazzini, Vincent I.; Winfree, Christopher J.; Choudhri, Haroon F.; Prestigiacomo, Charles J.; Solomon, Robert A.

In: Neurosurgery, Vol. 34, No. 6, 06.1994, p. 1040-1046.

Research output: Contribution to journalArticle

Frazzini, Vincent I. ; Winfree, Christopher J. ; Choudhri, Haroon F. ; Prestigiacomo, Charles J. ; Solomon, Robert A. / Mild hypothermia and mk-801 have similar but not additive degrees of cerebroprotection in the rat permanent focal ischemia model. In: Neurosurgery. 1994 ; Vol. 34, No. 6. pp. 1040-1046.
@article{99332c6c586546cfb43d2bf2199e4ed2,
title = "Mild hypothermia and mk-801 have similar but not additive degrees of cerebroprotection in the rat permanent focal ischemia model",
abstract = "ALTHOUGH NOT THE sole factor, glutamate-mediated excitotoxicity is accepted as a major mechanism of ischemic neuronal damage. MK-801 and mild hypothermia, two cerebroprotective modalities, which have been documented to alter glutamatergic action, were tested in the rat middle cerebral artery occlusion (MCAO) model simulating permanent focal ischemia. We administered normothermic (37°C) animals with either MK-801 (1.0 mg/kg 30 min before MCAO or 2.5 mg/kg 30 min before, immediately after, 4 hours, and 8 hours after MCAO) or saline vehicle (30 min before MCAO). Mildly hypothermic (33°C) animals were administered either MK-801 (1.0 mg/kg) or saline vehicle 30 minutes before MCAO. Mild hypothermia was induced over a 20-minute period before MCAO in hypothermic animals. All animals were killed 24 hours after MCAO; their brains were sectioned and stained with 2,3,5-triphenyltetrazolium chloride and their infarct volumes were calculated. In normothermica animals given 1.0 mg/kg and multidose 2.5-mg/kg intraperitoneal injections of MK-801, the infarct volumes (as a percentage of right hemispheric volume) were 16.8 ± 3.5{\%} and 16.3 ± 3.0{\%}, respectively. These infarct volumes were significantly different (P < 0.05; single-variable analysis of variance) from the normothermic, drug-free control (26.8 ± 1.9{\%}), but not significantly different from each other. Analysis of the data using a nonparametric test (Kruskal-Wallis; P = 0.02) confirmed the same significant differences in infarct size. The infarct volumes from the mildly hypothermic groups were not different (1 mg/kg of MK-801, 15.5 ± 2.3{\%} and saline control, 15.4 ± 1.1{\%}). However, the percentage of infarct size in the mildly hypothermic drug-free group was significantly reduced compared with the normothermic drug-free control (P < 0.0005; two-tailed Student's t-test). There was no significant difference between normothermic and mildly hypothermic animals given 1 mg/kg of MK-801. Therefore, in a rat permanent focal cerebral ischemia model, it appears that mild hypothermia and MK-801 offer similar cerebroprotective effects when administered separately, but do not yield additive effects when used in combination.",
keywords = "Cerebral ischemia, Dizocilpine, Hypothermia, Middle cerebral artery occlusion, Mk-801",
author = "Frazzini, {Vincent I.} and Winfree, {Christopher J.} and Choudhri, {Haroon F.} and Prestigiacomo, {Charles J.} and Solomon, {Robert A.}",
year = "1994",
month = "6",
doi = "10.1227/00006123-199406000-00013",
language = "English (US)",
volume = "34",
pages = "1040--1046",
journal = "Neurosurgery",
issn = "0148-396X",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Mild hypothermia and mk-801 have similar but not additive degrees of cerebroprotection in the rat permanent focal ischemia model

AU - Frazzini, Vincent I.

AU - Winfree, Christopher J.

AU - Choudhri, Haroon F.

AU - Prestigiacomo, Charles J.

AU - Solomon, Robert A.

PY - 1994/6

Y1 - 1994/6

N2 - ALTHOUGH NOT THE sole factor, glutamate-mediated excitotoxicity is accepted as a major mechanism of ischemic neuronal damage. MK-801 and mild hypothermia, two cerebroprotective modalities, which have been documented to alter glutamatergic action, were tested in the rat middle cerebral artery occlusion (MCAO) model simulating permanent focal ischemia. We administered normothermic (37°C) animals with either MK-801 (1.0 mg/kg 30 min before MCAO or 2.5 mg/kg 30 min before, immediately after, 4 hours, and 8 hours after MCAO) or saline vehicle (30 min before MCAO). Mildly hypothermic (33°C) animals were administered either MK-801 (1.0 mg/kg) or saline vehicle 30 minutes before MCAO. Mild hypothermia was induced over a 20-minute period before MCAO in hypothermic animals. All animals were killed 24 hours after MCAO; their brains were sectioned and stained with 2,3,5-triphenyltetrazolium chloride and their infarct volumes were calculated. In normothermica animals given 1.0 mg/kg and multidose 2.5-mg/kg intraperitoneal injections of MK-801, the infarct volumes (as a percentage of right hemispheric volume) were 16.8 ± 3.5% and 16.3 ± 3.0%, respectively. These infarct volumes were significantly different (P < 0.05; single-variable analysis of variance) from the normothermic, drug-free control (26.8 ± 1.9%), but not significantly different from each other. Analysis of the data using a nonparametric test (Kruskal-Wallis; P = 0.02) confirmed the same significant differences in infarct size. The infarct volumes from the mildly hypothermic groups were not different (1 mg/kg of MK-801, 15.5 ± 2.3% and saline control, 15.4 ± 1.1%). However, the percentage of infarct size in the mildly hypothermic drug-free group was significantly reduced compared with the normothermic drug-free control (P < 0.0005; two-tailed Student's t-test). There was no significant difference between normothermic and mildly hypothermic animals given 1 mg/kg of MK-801. Therefore, in a rat permanent focal cerebral ischemia model, it appears that mild hypothermia and MK-801 offer similar cerebroprotective effects when administered separately, but do not yield additive effects when used in combination.

AB - ALTHOUGH NOT THE sole factor, glutamate-mediated excitotoxicity is accepted as a major mechanism of ischemic neuronal damage. MK-801 and mild hypothermia, two cerebroprotective modalities, which have been documented to alter glutamatergic action, were tested in the rat middle cerebral artery occlusion (MCAO) model simulating permanent focal ischemia. We administered normothermic (37°C) animals with either MK-801 (1.0 mg/kg 30 min before MCAO or 2.5 mg/kg 30 min before, immediately after, 4 hours, and 8 hours after MCAO) or saline vehicle (30 min before MCAO). Mildly hypothermic (33°C) animals were administered either MK-801 (1.0 mg/kg) or saline vehicle 30 minutes before MCAO. Mild hypothermia was induced over a 20-minute period before MCAO in hypothermic animals. All animals were killed 24 hours after MCAO; their brains were sectioned and stained with 2,3,5-triphenyltetrazolium chloride and their infarct volumes were calculated. In normothermica animals given 1.0 mg/kg and multidose 2.5-mg/kg intraperitoneal injections of MK-801, the infarct volumes (as a percentage of right hemispheric volume) were 16.8 ± 3.5% and 16.3 ± 3.0%, respectively. These infarct volumes were significantly different (P < 0.05; single-variable analysis of variance) from the normothermic, drug-free control (26.8 ± 1.9%), but not significantly different from each other. Analysis of the data using a nonparametric test (Kruskal-Wallis; P = 0.02) confirmed the same significant differences in infarct size. The infarct volumes from the mildly hypothermic groups were not different (1 mg/kg of MK-801, 15.5 ± 2.3% and saline control, 15.4 ± 1.1%). However, the percentage of infarct size in the mildly hypothermic drug-free group was significantly reduced compared with the normothermic drug-free control (P < 0.0005; two-tailed Student's t-test). There was no significant difference between normothermic and mildly hypothermic animals given 1 mg/kg of MK-801. Therefore, in a rat permanent focal cerebral ischemia model, it appears that mild hypothermia and MK-801 offer similar cerebroprotective effects when administered separately, but do not yield additive effects when used in combination.

KW - Cerebral ischemia

KW - Dizocilpine

KW - Hypothermia

KW - Middle cerebral artery occlusion

KW - Mk-801

UR - http://www.scopus.com/inward/record.url?scp=0028275984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028275984&partnerID=8YFLogxK

U2 - 10.1227/00006123-199406000-00013

DO - 10.1227/00006123-199406000-00013

M3 - Article

C2 - 7916129

AN - SCOPUS:0028275984

VL - 34

SP - 1040

EP - 1046

JO - Neurosurgery

JF - Neurosurgery

SN - 0148-396X

IS - 6

ER -